Insilico Medicine vs Splunk

AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.

Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.

Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.

AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.

End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.

Integrated threat detection, investigation and response platform with agentic AI, SOAR, UEBA and SIEM unified into one SecOps experience.

AIOps and service-intelligence solution that uses AI-driven field discovery and AI-generated event correlation, summaries and root-cause guidance to connect IT events to business service health.

Observability platform where AI agents correlate signals across domains, propose remediation actions such as rollbacks or capacity changes, and provide dedicated agent/AI-system observability alongside infrastructure monitoring.

Assistant inside Splunk Cloud Platform that turns plain-English questions into SPL, the query language Splunk searches machine data with, and explains existing searches back to an analyst.